Artificial intelligence and machine learning may be ideal for picking up the day-to-day tasks of running enterprises, but still fall flat when it comes to innovation or reacting to unforeseen or one-off events. While enterprise-grade AI is still a ways off, it's incumbent on business and IT leaders to start piloting and exploring the advantages AI potentially offers. That's the word coming out of a recent report from the MIT Task Force on the Work of the Future, which looked at AI as part of a broad range of changes sweeping the employment scene and workplace. "We are a long way from AI systems that can read the news, re-plan supply chains in response to anticipated events like Brexit or trade disputes, and adapt production tasks to new sources of parts and materials," state the report's authors, David Autor of the National Bureau of Economic Research, along with David Mindell and Elisabeth Reynolds, both with MIT. For starters, data – the fuel that propels AI decision-making – is not ready for the leap.

Artificial intelligence and machine learning may be ideal for picking up the day-to-day tasks of running enterprises, but still fall flat when it comes to innovation or reacting to unforeseen or one-off events. While enterprise-grade AI is still a ways off, it's incumbent on business and IT leaders to start piloting and exploring the advantages AI potentially offers. That's the word coming out of a recent report from the MIT Task Force on the Work of the Future, which looked at AI as part of a broad range of changes sweeping the employment scene and workplace. "We are a long way from AI systems that can read the news, re-plan supply chains in response to anticipated events like Brexit or trade disputes, and adapt production tasks to new sources of parts and materials," state the report's authors, David Autor of the National Bureau of Economic Research, along with David Mindell and Elisabeth Reynolds, both with MIT. For starters, data – the fuel that propels AI decision-making – is not ready for the leap.

But Dr Louise Cullen, an emergency physician at the Royal Brisbane and Women's Hospital and one of the study's authors, said there were arbitrary cut-offs for troponin levels considered to be an indicator of a heart attack. "We see people come to hospital with heart damage and high levels of troponin, some of them are having a heart attack and some have other causes," Dr Cullen said. "There's an arbitrary cut-off point for indicating a heart attack based on a so-called normal population. "The problem is we know the older you get and whether you're male or female makes a difference on what that value should be.

But Dr Louise Cullen, an emergency physician at the Royal Brisbane and Women's Hospital and one of the study's authors, said there were arbitrary cut-offs for troponin levels considered to be an indicator of a heart attack. "We see people come to hospital with heart damage and high levels of troponin, some of them are having a heart attack and some have other causes," Dr Cullen said. "There's an arbitrary cut-off point for indicating a heart attack based on a so-called normal population. "The problem is we know the older you get and whether you're male or female makes a difference on what that value should be.

IN a world today that is increasingly looking like what was shown in the Jetsons cartoon series in the mid-1980s there are serious questions being asked about the future of the work and whether technology will destroy jobs. "Will robots steal our jobs; will my boss be an algorithm?" As ILO celebrates the completion of 100 years of its being it believes it will have to redefine what an employee and an employer may be in future; factor in new working time and figure out what a workplace may entail, to be able to draw new work policies, law and regulations. It will have to especially look at people that are doing gigs, by choice or otherwise. Gigs, for the uninitiated, mean a job for a specified, usually short, period of time -- like freelancers, consultants working on a project or even part-time hires. A recent study by online jobs marketplace Upwork found an estimated 4.1 million (or one-third of the workforce) Australians are freelancing.

The attack comes after Iran exceeded their enriched uranium stockpile limit in the nuclear deal. Secretary of State Mike Pompeo called on the international community to join him Saturday in condemning Iran for drone attacks on two Saudi oil facilities, which he described as "an unprecedented attack on the world's energy supply." "Tehran is behind nearly 100 attacks on Saudi Arabia while [President Hassan] Rouhani and [Foreign Minister Mohammad] Zarif pretend to engage in diplomacy," Pompeo tweeted, referring to the nation's president and foreign affairs minister. There is no evidence the attacks came from Yemen." Iran-backed Houthi rebels in Yemen claimed responsibility for the attack hours before Pompeo's tweet. The world's largest oil processing facility in Saudi Arabia and a major oil field were impacted, sparking huge fires at a vulnerable chokepoint for global energy supplies. "The United States will work with our partners and allies to ensure that energy markets remain well supplied and Iran is held accountable for its aggression," Pompeo concluded. According to multiple news reports that cited unidentified sources, the drone attacks affected up to half of the supplies from the world's largest exporter of oil, though the output should be restored within days. It remained unclear if anyone was injured at the Abqaiq oil processing facility and the Khurais oil field. Sen. Chris Murphy, D-Conn., who sits on the Senate Foreign Relations Committee, denounced Pompeo's description of the attack, calling it an "irresponsible simplification." "The Saudis and Houthis are at war.

Every year, more than 17,000 people in Germany are diagnosed with head and neck cancers. These include cancers of the oral cavity, larynx and nose, but can also affect other areas of the head and neck. Some head and neck cancer patients will also develop lung cancer. "In the large majority of cases, it is impossible to determine whether these represent pulmonary metastases of the patient's head and neck cancer or a second primary cancer, i.e. primary lung cancer," explains Prof. Dr. Frederick Klauschen of Charité's Institute of Pathology, who co-led the study alongside Prof. Dr. David Capper of Charité's Department of Neuropathology. "This distinction is hugely important in the treatment of people affected by these cancers," emphasizes Prof. Klauschen, adding: "While surgery may provide a cure in patients with localized lung cancers, patients with metastatic head and neck cancers fare significantly worse in terms of survival and will require treatments such as chemoradiotherapy."

One of the hot topics at SXSW this year is Artificial Intelligence and its impact on humans, society and work. Deep learning evolved so fast the past year that there are numerous new applications and tools arising that benefit from and use this new technology. In the panel discussion, 'AI the future of storytelling, 'AI the future of storytelling', industry leaders discussed their take on the topic. One of the most interesting stories around AI is the Portrait of Edmond Belamy, which was recently sold at Christie's for 432,000 dollars. The painting, however, is not the product of a human painter.

As artificial intelligence works its way into industries like healthcare and finance, governments around the world are increasingly investing in another of its applications: autonomous weapons systems. Many are already developing programs and technologies that they hope will give them an edge over their adversaries, creating mounting pressure for others to follow suite. These investments appear to mark the early stages of an AI arms race. Much like the nuclear arms race of the 20th century, this type of military escalation poses a threat to all humanity and is ultimately unwinnable. It incentivizes speed over safety and ethics in the development of new technologies, and as these technologies proliferate it offers no long-term advantage to any one player.

My nose is pressed to the glass as I watch thousands of human cellular samples whisk by, running through a large, elaborate machine. There are lab workers bustling around in neatly pressed lab coats, jotting down notes on their clipboards. It looks like a scene from a futuristic movie. This is real life, and the technology in use is poised to change the world of healthcare as we know it. "I never wanted to work for a pharmaceutical company," says Amanda Guisbond, the director of corporate communications at Recursion Pharmaceuticals.